Freddie Mac October Forecast: Housing Market Remains Strong While Economic Slowdown Looms
/
Date01 Nov 2019
Email Print Friendly Share October Forecast Forecast Snapshot (October 2019) Freddie Mac MCLEAN, Va., Oct. 31, 2019 (GLOBE NEWSWIRE) — According to Freddie Mac’s (OTCQB:... Read More →
Rebel Capital Inc. Announces Termination of Qualifying Transaction
/
Date01 Nov 2019
Email Print Friendly Share THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES... Read More →
Terrafina Announces Distribution Payment Corresponding to Third Quarter 2019
/
Date01 Nov 2019
Email Print Friendly Share MEXICO CITY, Oct. 31, 2019 (GLOBE NEWSWIRE) — Terrafina (“TERRA”) (BMV: TERRA13), a leading Mexican industrial real estate investment trust (“FIBRA”),... Read More →
Carolina Trust BancShares, Inc. Reports 3rd Quarter 2019 Results
/
Date01 Nov 2019
Email Print Friendly Share $0.15 Net Income Per Diluted Share for the third quarter of 2019 as compared to $0.13 for the third quarter of... Read More →
Raven Enters Into Agreement to Acquire Majority Ownership in DOT™, Leader in Autonomous Platforms
/
Date01 Nov 2019
Email Print Friendly Share SIOUX FALLS, S.D., Oct. 31, 2019 (GLOBE NEWSWIRE) — Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today that it has entered... Read More →
SWM ANNOUNCES CONFERENCE CALL TO DISCUSS THIRD QUARTER 2019 RESULTS
/
Date01 Nov 2019
Email Print Friendly Share Alpharetta, GA, Oct. 31, 2019 (GLOBE NEWSWIRE) — Schweitzer-Mauduit International, Inc. (NYSE: SWM) will issue a press release announcing the Company’s... Read More →
Artefact : Rapport financier semestriel
/
Date01 Nov 2019
Email Print Friendly Share Rapport semestriel ARTEFACT 2019 Vdef Pièce jointe Rapport semestriel ARTEFACT 2019 Vdef
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/
Date01 Nov 2019
Email Print Friendly Share CAMBRIDGE, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases,... Read More →
FinServ Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering
/
Date01 Nov 2019
Email Print Friendly Share New York, NY, Oct. 31, 2019 (GLOBE NEWSWIRE) — FinServ Acquisition Corp. (the “Company”) announced today that it priced its initial... Read More →